Salt-inducible kinase 1 regulates bone anabolism via the CRTC1–CREB–Id1 axis
Open Access
- 31 October 2019
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 10 (11) , 1-15
Abstract
New bone anabolic agents for the effective treatment of bone metabolic diseases like osteoporosis are of high clinical demand. In the present study, we reveal the function of salt-inducible kinase 1 (SIK1) in regulating osteoblast differentiation. Gene knockdown of SIK1 but not of SIK2 or SIK3 expression in primary preosteoblasts increased osteoblast differentiation and bone matrix mineralization. SIK1 also regulated the proliferation of osteoblastic precursor cells in osteogenesis. This negative control of osteoblasts required the catalytic activity of SIK1. SIK1 phosphorylated CREB regulated transcription coactivator 1 (CRTC1), preventing CRTC1 from enhancing CREB transcriptional activity for the expression of osteogenic genes like Id1. Furthermore, SIK1 knockout (KO) mice had higher bone mass, osteoblast number, and bone formation rate versus littermate wild-type (WT) mice. Preosteoblasts from SIK1 KO mice showed more osteoblastogenic potential than did WT cells, whereas osteoclast generation among KO and WT precursors was indifferent. In addition, bone morphogenic protein 2 (BMP2) suppressed both SIK1 expression as well as SIK1 activity by protein kinase A (PKA)–dependent mechanisms to stimulate osteogenesis. Taken together, our results indicate that SIK1 is a key negative regulator of preosteoblast proliferation and osteoblast differentiation and that the repression of SIK1 is crucial for BMP2 signaling for osteogenesis. Therefore, we propose SIK1 to be a useful therapeutic target for the development of bone anabolic strategies.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2018R1A5A2024418, NRF-2018R1A5NRF-2017R1A2A1A17069648A2024418, NRF-2018R1A5A2024418, NRF-2017R1A2A1A17069648, NRF-2018R1A5A2024418, NRF-2017R1A2A1A17069648, NRF-2017R1A2B2002312, NRF-2017R1A2B2002312, NRF-2018R1A5A2024418, NRF-2017R1A2A1A17069648, NRF-2017R1A2B2002312, NRF-2017R1A2B2002312)
This publication has 75 references indexed in Scilit:
- Plasma membrane calcium ATPase regulates bone mass by fine-tuning osteoclast differentiation and survivalJournal of Cell Biology, 2012
- The AMPK-related kinase SIK2 is regulated by cAMP via phosphorylation at Ser358 in adipocytesBiochemical Journal, 2012
- Balancing Life and Death in the Ischemic Brain: SIK and TORC Weigh InNeuron, 2011
- Molecular basis of parathyroid hormone receptor signaling and trafficking: a family B GPCR paradigmCellular and Molecular Life Sciences, 2010
- The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in miceJournal of Clinical Investigation, 2010
- Targeting of renal proximal tubule Na,K-ATPase by salt-inducible kinaseBiochemical and Biophysical Research Communications, 2010
- PTH and PTHrP signaling in osteoblastsCellular Signalling, 2009
- Adverse Effects of Bisphosphonates: Implications for Osteoporosis ManagementMayo Clinic Proceedings, 2009
- cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivoProceedings of the National Academy of Sciences, 2008
- KIN‐29 SIK regulates chemoreceptor gene expression via an MEF2 transcription factor and a class II HDACThe EMBO Journal, 2006